CoChat

Astrocyte Senescence as a Component of Alzheimer’s Disease

Open access

The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.

Abstract

Aging is the main risk factor for Alzheimer's disease (AD); however, the aspects of the aging process that predispose the brain to the development of AD are largely unknown. Astrocytes perform a myriad of functions in the central nervous system to maintain homeostasis and support neuronal function. In vitro, human astrocytes are highly sensitive to oxidative stress and trigger a senescence program when faced with multiple types of stress. In order to determine whether senescent astrocytes appear in vivo, brain tissue from aged individuals and patients with AD was examined for the presence of senescent astrocytes using p16(INK4a) and matrix metalloproteinase-1 (MMP-1) expression as markers of senescence. Compared with fetal tissue samples (n = 4), a significant increase in p16(INK4a)-positive astrocytes was observed in subjects aged 35 to 50 years (n = 6; P = 0.02) and 78 to 90 years (n = 11; P<10(-6)). In addition, the frontal cortex of AD patients (n = 15) harbored a significantly greater burden of p16(INK4a)-positive astrocytes compared with non-AD adult control subjects of similar ages (n = 25; P = 0.02) and fetal controls (n = 4; P<10(-7)). Consistent with the senescent nature of the p16(INK4a)-positive astrocytes, increased metalloproteinase MMP-1 correlated with p16(INK4a). In vitro, beta-amyloid 1-42 (Aβ(1-42)) triggered senescence, driving the expression of p16(INK4a) and senescence-associated beta-galactosidase. In addition, we found that senescent astrocytes produce a number of inflammatory cytokines including interleukin-6 (IL-6), which seems to be regulated by p38MAPK. We propose that an accumulation of p16(INK4a)-positive senescent astrocytes may link increased age and increased risk for sporadic AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0045069

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Astrocytes trigger senescence in response to Aβ1–42. (A) Representative images of astrocytes treated with conditioned media from 7PA2 Aβ-secreting Chinese Hamster Ovary (CHO) cells or CHO control cells as described in Figure S2. Graph shows relative amount of SA β-gal-positive cells from 3 independent experiments, *P = 0.039. (B) Representative images of astrocytes treated with oligomerized synthetic Aβ1–42 for 2 hours and assayed for SA β-gal activity after 3 days. Graph shows relative levels of SAβ-gal–positive cells from 3 independent experiments, *P = 0.017, Aβ1–42 (5 µM and **P = 0.009, Aβ1–42 (10 µM) vs. control. (C) Immunoblot for p16INK4a expression in astrocytes treated with 5 µM Aβ1–42 for 24 hours. Lysate was collected 4 days after treatment initiation. β-actin serves as a loading control. Graph depicts normalized optical density of the ratio of p16INK4a:β-actin, *P = 0.02. For all experiments, error bars represent SD and Student’s t-test was used to determine significance.
Figure 1 Astrocytes trigger senescence in response to Aβ1–42. (A) Representative images of astrocytes treated with conditioned media from 7PA2 Aβ-secreting Chinese Hamster Ovary (CHO) cells or CHO control cells as described in Figure S2. Graph shows relative amount of SA β-gal-positive cells from 3 independent experiments, *P = 0.039. (B) Representative images of astrocytes treated with oligomerized synthetic Aβ1–42 for 2 hours and assayed for SA β-gal activity after 3 days. Graph shows relative levels of SAβ-gal–positive cells from 3 independent experiments, *P = 0.017, Aβ1–42 (5 µM and **P = 0.009, Aβ1–42 (10 µM) vs. control. (C) Immunoblot for p16INK4a expression in astrocytes treated with 5 µM Aβ1–42 for 24 hours. Lysate was collected 4 days after treatment initiation. β-actin serves as a loading control. Graph depicts normalized optical density of the ratio of p16INK4a:β-actin, *P = 0.02. For all experiments, error bars represent SD and Student’s t-test was used to determine significance.CC BY · PubMed Central
Figure 2 Senescent astrocytes secrete pro-inflammatory mediators that may constitute a SASP. Pre-senescent and senescent astrocytes were incubated in serum-free MCDB105 media. Conditioned media was collected after 48 hours and analyzed by antibody array (RayBiotech, Inc.; Norcross, GA) for pro-inflammatory factors as described in Materials and Methods.
Figure 2 Senescent astrocytes secrete pro-inflammatory mediators that may constitute a SASP. Pre-senescent and senescent astrocytes were incubated in serum-free MCDB105 media. Conditioned media was collected after 48 hours and analyzed by antibody array (RayBiotech, Inc.; Norcross, GA) for pro-inflammatory factors as described in Materials and Methods.CC BY · PubMed Central
Figure 3 Increased frequency of senescent astrocytes during brain aging and AD. p16INK4a-positive astrocytes were identified in formalin-fixed, paraffin-embedded frontal cortex sections by double immunofluorescence with p16INK4a/GFAP. (A) Double immunofluorescence with p16INK4a/GFAP showing increased p16INK4a-positive astrocytes with increased age and AD (representative images). Blue: DAPI; green: GFAP; red: p16INK4a. Arrows indicate p16INK4a-positive astrocytes. (B) Bar diagram shows increased mean p16 INK4a-positive astrocytes in frontal cortices from non-AD adult subjects (35–50 years, n = 6; 78–90 years, n = 11) as compared to fetal autopsy tissue (n = 4). *P = 0.02, fetal vs. 35–50 year olds; **P<10−6, fetal vs. 78–90 year olds; Student’s t-test. (C) Bar diagram shows increased mean p16 INK4a-positive astrocytes in frontal cortices from AD adult subjects (n = 15) compared to non-AD adult control subjects (n = 25) of similar ages; and fetal controls (n = 4). * P = 0.02, AD vs. adult controls; ***P<10−7, AD vs. fetal controls, and **P<10−6, adult controls vs. fetal controls. Error bars represent SD and Student’s t-test was used to determine significance. At least 200 cells were counted per slide.
Figure 3 Increased frequency of senescent astrocytes during brain aging and AD. p16INK4a-positive astrocytes were identified in formalin-fixed, paraffin-embedded frontal cortex sections by double immunofluorescence with p16INK4a/GFAP. (A) Double immunofluorescence with p16INK4a/GFAP showing increased p16INK4a-positive astrocytes with increased age and AD (representative images). Blue: DAPI; green: GFAP; red: p16INK4a. Arrows indicate p16INK4a-positive astrocytes. (B) Bar diagram shows increased mean p16 INK4a-positive astrocytes in frontal cortices from non-AD adult subjects (35–50 years, n = 6; 78–90 years, n = 11) as compared to fetal autopsy tissue (n = 4). *P = 0.02, fetal vs. 35–50 year olds; **P<10−6, fetal vs. 78–90 year olds; Student’s t-test. (C) Bar diagram shows increased mean p16 INK4a-positive astrocytes in frontal cortices from AD adult subjects (n = 15) compared to non-AD adult control subjects (n = 25) of similar ages; and fetal controls (n = 4). * P = 0.02, AD vs. adult controls; ***P<10−7, AD vs. fetal controls, and **P<10−6, adult controls vs. fetal controls. Error bars represent SD and Student’s t-test was used to determine significance. At least 200 cells were counted per slide.CC BY · PubMed Central
Figure 4 Expression level of p16INK4a is not elevated in adult cerebellar astrocytes. (A) Representative images of cerebellum from an AD patient showing intensely p16INK4a positive granular layer. The Bergmann glia (arrowhead) and Purkinje neurons (arrow) are negative. Blue: DAPI; Green: GFAP; Red: p16INK4a. (B) Bar diagram shows increased mean percentage of p16INK4a-positive astrocytes in formalin-fixed, paraffin-embedded cortical sections from AD subjects (n = 3) and control subjects (n = 3) compared to cerebellum from both AD and aged-matched controls (n = 6). The mean percentage of p16INK4a-positive astrocytes in cerebellum is comparable to fetal cortical levels. *P = 0.04, Student’s t test, cerebellum vs. control cortices; **P = 0.004, Student’s t test, cerebellum vs. AD cortices. Error bars represent SD At least 200 cells per slide were counted for the cortical sections, and at least 100 cells per slide were counted for the cerebellar sections.
Figure 4 Expression level of p16INK4a is not elevated in adult cerebellar astrocytes. (A) Representative images of cerebellum from an AD patient showing intensely p16INK4a positive granular layer. The Bergmann glia (arrowhead) and Purkinje neurons (arrow) are negative. Blue: DAPI; Green: GFAP; Red: p16INK4a. (B) Bar diagram shows increased mean percentage of p16INK4a-positive astrocytes in formalin-fixed, paraffin-embedded cortical sections from AD subjects (n = 3) and control subjects (n = 3) compared to cerebellum from both AD and aged-matched controls (n = 6). The mean percentage of p16INK4a-positive astrocytes in cerebellum is comparable to fetal cortical levels. *P = 0.04, Student’s t test, cerebellum vs. control cortices; **P = 0.004, Student’s t test, cerebellum vs. AD cortices. Error bars represent SD At least 200 cells per slide were counted for the cortical sections, and at least 100 cells per slide were counted for the cerebellar sections.CC BY · PubMed Central
Figure 5 MMP-1 expression parallels p16INK4a expression in human astrocytes in vivo. (A) Double immunofluorescence with MMP-1/GFAP in AD and a similar-aged control (representative images). Blue: DAPI; red: GFAP; green: MMP-1. Arrows indicate MMP-1–positive astrocytes. Inset shows magnified image of MMP-1-positive astrocytes (yellow: cytoplasmic). (B) Bar diagram shows positive correlation between MMP-1 and p16INK4a expression in human frontal cortex, independent of diagnosis, P = 0.02, Spearman’s correlation coefficient = 0.574.
Figure 5 MMP-1 expression parallels p16INK4a expression in human astrocytes in vivo. (A) Double immunofluorescence with MMP-1/GFAP in AD and a similar-aged control (representative images). Blue: DAPI; red: GFAP; green: MMP-1. Arrows indicate MMP-1–positive astrocytes. Inset shows magnified image of MMP-1-positive astrocytes (yellow: cytoplasmic). (B) Bar diagram shows positive correlation between MMP-1 and p16INK4a expression in human frontal cortex, independent of diagnosis, P = 0.02, Spearman’s correlation coefficient = 0.574.CC BY · PubMed Central
Figure 6 p38MAPK pathway is activated and modulates IL-6 secretion in astrocytes. (A) Western blots depict the levels of total and phosphorylated p38MAPK and heat shock protein 27 (Hsp27) in pre-senescent and H2O2-induced senescent astrocytes with β-actin as loading control. (B) Pre-senescent and senescent astrocytes were treated with 10 µM SB-203580 or DMSO as a control for 48 hours prior to incubation in serum-free MCDB105 media. Conditioned media was collected after 24 hours and IL-6 was analyzed by ELISA (R&D Systems, Inc.; Minneapolis, MN) and normalized to cell number. Graph depicts the relative level of IL-6 (n = 3), *P<0.01 vs. senescent, Student’s t test.
Figure 6 p38MAPK pathway is activated and modulates IL-6 secretion in astrocytes. (A) Western blots depict the levels of total and phosphorylated p38MAPK and heat shock protein 27 (Hsp27) in pre-senescent and H2O2-induced senescent astrocytes with β-actin as loading control. (B) Pre-senescent and senescent astrocytes were treated with 10 µM SB-203580 or DMSO as a control for 48 hours prior to incubation in serum-free MCDB105 media. Conditioned media was collected after 24 hours and IL-6 was analyzed by ELISA (R&D Systems, Inc.; Minneapolis, MN) and normalized to cell number. Graph depicts the relative level of IL-6 (n = 3), *P<0.01 vs. senescent, Student’s t test.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

5 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 63 references

Cited by

See all 589

Metadata

Authors
Bhat, R., Crowe, E. P., Bitto, A., Moh, M., Katsetos, C. D., Garcia, F. U., Johnson, F. B., Trojanowski, J. Q., Sell, C., & Torres, C.
Affiliations
  • Drexel University (US)
  • University of Pennsylvania (US)
Corresponding author
Torres, Claudio
Venue
PLoS ONE
Published
2012-09-12
Volume
7
Issue
9
Pages
e45069
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2026433865
Cited by
586
References
64
Citations by year
2026: 44 · 2025: 56 · 2024: 68 · 2023: 54 · 2022: 52 · 2021: 59 · 2020: 53 · 2019: 47 · 2018: 37 · 2017: 27 · 2016: 31 · 2015: 17 · 2014: 30 · 2013: 7 · 2012: 3
FWCI
12.23
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • Drexel University
  • National Institutes of Health
  • University of California, San Diego
  • College of Medicine, Drexel University
  • National Institute on Aging (AG022443-S1, AG022443, R01AG022443)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
astrocyte senescence, Alzheimer's disease, aging, p16INK4a, MMP-1, amyloid-beta 42, oxidative stress, senescence-associated β-galactosidase, interleukin-6, p38 MAPK, neuroinflammation, frontal cortex, sporadic Alzheimer's disease
MeSH terms
Adult, Aged, Aged, 80 and over, Alzheimer Disease, Animals, Astrocytes, Brain, Cells, Cultured, Cricetulus, Female, Cricetinae, Humans, Male, Microscopy, Fluorescence, Middle Aged, Peptide Fragments, Immunoblotting, Biomarkers, Interleukin-6, Amyloid beta-Peptides, CHO Cells, Cellular Senescence, Cyclin-Dependent Kinase Inhibitor p16, Matrix Metalloproteinase 1, p38 Mitogen-Activated Protein Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Astrocyte Senescence as a Component of Alzheimer’s Disease. https://app.cochat.ai/papers/10.1371/journal.pone.0045069
The paper
Bhat, R., Crowe, E. P., Bitto, A., Moh, M., Katsetos, C. D., Garcia, F. U., Johnson, F. B., Trojanowski, J. Q., Sell, C., & Torres, C. (2012). Astrocyte Senescence as a Component of Alzheimer’s Disease. PLoS ONE. https://doi.org/10.1371/journal.pone.0045069

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.